Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
HYPR 
Hyperfine Inc (HYPR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/14/2025: HYPR (3-star) is a STRONG-BUY. BUY since 66 days. Simulated Profits (156.25%). Updated daily EoD!
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $1.42
1 Year Target Price $1.42
| 2 | Strong Buy |
| 0 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 144.23% | Avg. Invested days 38 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 10/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 137.52M USD | Price to earnings Ratio - | 1Y Target Price 1.42 |
Price to earnings Ratio - | 1Y Target Price 1.42 | ||
Volume (30-day avg) 4 | Beta 1.11 | 52 Weeks Range 0.53 - 2.19 | Updated Date 10/14/2025 |
52 Weeks Range 0.53 - 2.19 | Updated Date 10/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.52 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -355.9% |
Management Effectiveness
Return on Assets (TTM) -43.32% | Return on Equity (TTM) -77.26% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 87188830 | Price to Sales(TTM) 12.74 |
Enterprise Value 87188830 | Price to Sales(TTM) 12.74 | ||
Enterprise Value to Revenue 8.08 | Enterprise Value to EBITDA -0.72 | Shares Outstanding 63525713 | Shares Floating 59276792 |
Shares Outstanding 63525713 | Shares Floating 59276792 | ||
Percent Insiders 6.67 | Percent Institutions 14.29 |
Upturn AI SWOT
Hyperfine Inc
Company Overview
History and Background
Hyperfine, Inc. was founded in 2014 with the goal of reinventing MRI technology. It focuses on making MRI more accessible and convenient, moving it closer to the point of care.
Core Business Areas
- Portable MRI: Hyperfine's core business revolves around its portable MRI system, Swoop. It's designed to be wheeled to the patient's bedside for immediate imaging, differing from traditional stationary MRI machines.
Leadership and Structure
The leadership team consists of experienced professionals in medical technology and business. The organizational structure is typical of a medical device company, with departments for R&D, manufacturing, sales, and marketing.
Top Products and Market Share
Key Offerings
- Competitors: Siemens Healthineers (SIEGY), GE Healthcare (GE), Philips (PHG)
- Swoop Portable MRI: Swoop is Hyperfine's main product, a portable MRI system designed for point-of-care imaging. Market share data is limited, but Hyperfine is a relatively new entrant aiming to disrupt the traditional MRI market dominated by Siemens Healthineers (SIEGY), GE Healthcare (GE), and Philips (PHG).
Market Dynamics
Industry Overview
The medical imaging market, including MRI, is large and growing. The trend is toward more efficient, accessible, and cost-effective solutions.
Positioning
Hyperfine is positioning itself as a disruptor in the MRI market by offering a portable, lower-cost alternative to traditional MRI systems.
Total Addressable Market (TAM)
The global MRI market is projected to reach tens of billions of dollars. Hyperfine is targeting a segment of this market by providing accessible point-of-care solutions.
Upturn SWOT Analysis
Strengths
- Portable MRI technology
- Lower cost compared to traditional MRI
- Potential for wider accessibility
- FDA clearance for clinical use
Weaknesses
- Limited clinical evidence compared to traditional MRI
- Smaller installed base
- Reliance on single product
- Limited market share currently
Opportunities
- Expanding applications of portable MRI
- Partnerships with hospitals and healthcare systems
- International expansion
- Technological advancements in image quality and capabilities
Threats
- Competition from established MRI vendors
- Regulatory changes
- Reimbursement challenges
- Technological obsolescence
Competitors and Market Share
Key Competitors
- GE (GE)
- Siemens Healthineers (SIEGY)
- Philips (PHG)
Competitive Landscape
Hyperfine faces significant competition from established players. It needs to demonstrate the clinical and economic value of its portable MRI to gain market share.
Growth Trajectory and Initiatives
Historical Growth: Requires analysis of Hyperfine's revenue and sales growth over time.
Future Projections: Requires analyst reports and forecasts for Hyperfine.
Recent Initiatives: Includes expanding sales network and product development.
Summary
Hyperfine is a relatively new player aiming to disrupt the MRI market with its portable technology. It is still an emerging company with a single product and is facing fierce competition from established players. Hyperfine needs to focus on its product development to provide better imaging quality, and increase adoption by healthcare providers in order to grow revenue and market share. The company is risky for investment purposes due to not making profit.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- Press releases
- Industry reports
- Analyst reports
- SEC Filings
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It is not investment advice. Market share data is estimated.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Hyperfine Inc
Exchange NASDAQ | Headquaters Guilford, CT, United States | ||
IPO Launch date 2021-01-27 | CEO, President & Director Ms. Maria Sainz | ||
Sector Healthcare | Industry Medical Devices | Full time employees 111 | Website https://hyperfine.io |
Full time employees 111 | Website https://hyperfine.io | ||
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, New Zealand, and internationally. The company was founded in 2014 and is based in Guilford, Connecticut.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.